Evidence map›Paper›PMID 37808373›Full record

ArticleBioinformation2023

Colliding Pandemics and CoViD-19.

Lily Fotovat, Francesco Chiappelli

Open access · hybridAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lily FotovatDental Group of Sherman Oaks, CA 91403, USA (www.oliviacajulisdds.com).
Francesco ChiappelliDental Group of Sherman Oaks, CA 91403, USA (www.oliviacajulisdds.com).
Sherman Oaks Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cases of the respiratory syncytial virus (RSV), monkeypox virus (MPXV), and avian influenza A Virus (IAV) have increased during our current prolonged Corona Virus Disease 2019 (CoViD-19) pandemic. The rise of these viral infectious diseases may be associated or even inter-dependent with acute, latent or recurrent infection with Systemic Acute Respiratory Syndrome Corona virus-2 (SARS-CoV2). The nonsensical neologism 'tripledemic' was tentatively introduced to describe the confluent nature of these trends (epidemic comes from two Greek words:

Indexed as

Center for Disease Control (CDC)Centers for Disease Control (CDC)Corona Virus Disease 2019 (CoViD-19)fusion-associated small transmembrane proteins (FAST)Influenza A, B & C Virus (IAV, IBV, ICV)monkeypox virus (MPXV)oral manifestationsRespiratory Syncytial Virus (RSV)Spike (S) proteinSystemic Acute Respiratory Syndrome Corona virus-2 (SARS-CoV2)viral inferenceviral recombinationviral surface proteins: hemagglutinin (H) and neuraminidase (N) influenza viral surface proteinsWorld Health Organization (WHO)

Identifiers

PMID37808373
PMCPMC10557438
OpenAlexW4362718596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.